A detailed history of Vident Advisory, LLC transactions in Globus Medical Inc stock. As of the latest transaction made, Vident Advisory, LLC holds 3,830 shares of GMED stock, worth $270,551. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,830
Previous 3,893 1.62%
Holding current value
$270,551
Previous $209 Million 25.62%
% of portfolio
0.01%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$49.79 - $68.85 $3,136 - $4,337
-63 Reduced 1.62%
3,830 $262 Million
Q1 2024

May 14, 2024

BUY
$51.15 - $56.52 $2,710 - $2,995
53 Added 1.38%
3,893 $209 Million
Q4 2023

Feb 14, 2024

BUY
$43.79 - $55.14 $168,153 - $211,737
3,840 New
3,840 $205 Million

Others Institutions Holding GMED

About GLOBUS MEDICAL INC


  • Ticker GMED
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 77,037,200
  • Market Cap $5.44B
  • Description
  • Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devi...
More about GMED
Track This Portfolio

Track Vident Advisory, LLC Portfolio

Follow Vident Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vident Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vident Advisory, LLC with notifications on news.